![John Sørensen Haurum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Sørensen Haurum
Président chez
MONIVENT AB
Fortune : 3 M $ au 31/05/2026
Profil
John Sørensen Haurum was the founder of Servier Symphogen A, founded in 2000, where the title held was Chief Scientific Officer from 2009 to 2010.
Current jobs include Chief Executive Officer & Director at F-star Alpha Ltd., Executive Chairman at Synklino ApS, Chairman at Saniona AB starting in 2025, Co-Chairman at Monivent AB, Director at F-Star Beta Ltd. since 2014, Director at NeoPhore Ltd. since 2019, Director at DJS Antibodies Ltd. since 2021, and Director at Mc2 Therapeutics AS.
Former jobs include Chief Executive Officer at F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH and F-star Biotechnology Ltd., Independent Chairman at CatalYm GmbH, Chairman at AgomAb Therapeutics NV from 2019 to 2024, Chairman at ADCendo ApS, Director at SynAct Pharma AB, Independent Non-Executive Director at STORM Therapeutics Ltd., Vice President-Research at ImClone LLC from 2010 to 2012, and Associate Professor at Danish Cancer Society.
Education includes doctorates from the University of Oxford and the University of Aarhus.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SANIONA AB 1,25% | 02/12/2025 | 1 719 476 ( 1,25% ) | 3 M $ | 31/05/2026 |
Postes actifs de John Sørensen Haurum
| Sociétés | Poste | Début |
|---|---|---|
| SANA AB | Président | 01/05/2025 |
| MONIVENT AB | Président | - |
DJS Antibodies Ltd.
 DJS Antibodies Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 07/06/2021 |
Synklino ApS
 Synklino ApS Medical/Nursing ServicesHealth Services Provides organ and stem cell donation transplantations treatment services | Président | - |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Directeur/Membre du Conseil | 20/03/2019 |
F-Star Beta Ltd.
 F-Star Beta Ltd. BiotechnologyHealth Technology Researches and develops oncology and immuno-oncology compounds | Directeur/Membre du Conseil | 14/10/2014 |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Directeur Général | - |
Mc2 Therapeutics AS
 Mc2 Therapeutics AS Pharmaceuticals: MajorHealth Technology Manufactures therapies for chronic inflammatory diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de John Sørensen Haurum
| Sociétés | Poste | Fin |
|---|---|---|
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Président | 01/04/2025 |
| ░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de John Sørensen Haurum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Danish Cancer Society
 Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services Operates as disease-fighting association | Commercial Services |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Health Technology |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
Monivent AB
 Monivent AB Medical SpecialtiesHealth Technology Develops device to monitor manual ventilation given to newborns unable to breathe | Health Technology |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Health Technology |
F-Star Beta Ltd.
F-Star Beta Ltd. BiotechnologyHealth Technology Researches and develops oncology and immuno-oncology compounds | Health Technology |
CatalYm GmbH
 CatalYm GmbH Pharmaceuticals: MajorHealth Technology Specializes in catalyzing immunotherapy | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
DJS Antibodies Ltd.
DJS Antibodies Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
ADCendo ApS
ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Health Technology |
Mc2 Therapeutics AS
Mc2 Therapeutics AS Pharmaceuticals: MajorHealth Technology Manufactures therapies for chronic inflammatory diseases | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Synklino ApS
Synklino ApS Medical/Nursing ServicesHealth Services Provides organ and stem cell donation transplantations treatment services | Health Services |
